Optimising Clinical Trial Design for Proof of Neuroprotection in Acute Ischaemic Stroke: The SAINT Clinical Trial Programme

Publisher： Karger

E-ISSN： 1421-9786|22|1|18-24

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.22, Iss.1, 2006-06, pp. : 18-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcome Analysis in Clinical Trial Design for Acute Stroke: Physicians’ Attitudes and Choices

By  

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 156-162

Karger

Access to resources Recommend Favorite

Thrombolysis in Acute Childhood Stroke: Design and Challenges of the Thrombolysis in Pediatric Stroke Clinical Trial

By  

Neuroepidemiology, Vol. 32, Iss. 4, 2009-02 ,pp. : 279-286

Karger

Access to resources Recommend Favorite

Influence of Gender on Baseline Features and Clinical Outcomes among 17,370 Patients with Confirmed Ischaemic Stroke in the International Stroke Trial

By  

Neuroepidemiology, Vol. 24, Iss. 3, 2005-04 ,pp. : 123-128

Karger

Access to resources Recommend Favorite

Heparin in Acute Ischemic Stroke: The Case for a New Clinical Trial

By  

Cerebrovascular Diseases, Vol. 9, Iss. 3, 1999-07 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

Clinical Experience with Ancrod in Acute Ischaemic Stroke

By  

Cerebrovascular Diseases, Vol. 10, Iss. 4, 2000-10 ,pp. : 27-29

Karger

Access to resources Recommend Favorite